Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank J Giles

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Cancer Treatment and Research|December 16, 2018
Biosimilars: Are They Really Safe?June M McKoy, Frank J Giles
Cancer Chemotherapy and Pharmacology|May 25, 2012
Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemiaOphelia Q P Yin, Frank J Giles, Michele Baccarani, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Cancer Treatment and Research|December 16, 2018
Biosimilars: Are They Really Safe?June M McKoy, Frank J Giles
Cancer Chemotherapy and Pharmacology|May 25, 2012
Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemiaOphelia Q P Yin, Frank J Giles, Michele Baccarani, et al.
Pageof 1